Without the APOE component weight, the specificity of the DLB PRS emerged, as it was only associated with increased relative risk ratios for the DLB (3.58 [1.20–10.66]) and AD + DLB (3.15 [1.47–6.77]) groups compared to the control group. This evidence concerns the gene APOE and Alzheimer disease.